miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)

MLA

Xi He, et al. “MiR-4317 Suppresses Non-Small Cell Lung Cancer (NSCLC) by Targeting Fibroblast Growth Factor 9 (FGF9) and Cyclin D2 (CCND2).” Journal of Experimental & Clinical Cancer Research, vol. 37, no. 1, Sept. 2018, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s13046-018-0882-4.

APA

Xi He, Si-yuan Chen, Zhao Yang, Jie Zhang, Wei Wang, Mei-yue Liu, Yi Niu, Xiao-mei Wei, Hong-min Li, Wan-ning Hu, & Guo-gui Sun. (2018). miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2). Journal of Experimental & Clinical Cancer Research, 37(1), 1–16. https://doi.org/10.1186/s13046-018-0882-4

Chicago

Xi He, Si-yuan Chen, Zhao Yang, Jie Zhang, Wei Wang, Mei-yue Liu, Yi Niu, et al. 2018. “MiR-4317 Suppresses Non-Small Cell Lung Cancer (NSCLC) by Targeting Fibroblast Growth Factor 9 (FGF9) and Cyclin D2 (CCND2).” Journal of Experimental & Clinical Cancer Research 37 (1): 1–16. doi:10.1186/s13046-018-0882-4.